Avantor (AVTR) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
7 May, 2026Opening remarks and agenda
Meeting called to order at 11:00 A.M. with board members and key executives present.
Meeting conducted virtually with procedural rules and materials accessible online.
Quorum confirmed with 94% of outstanding shares represented.
Shareholder proposals
Election of nine directors recommended by the board for the next term.
Advisory vote on executive compensation recommended for approval.
Advisory vote on frequency of say-on-pay votes, with board recommending annual votes.
Ratification of Deloitte & Touche LLP as independent auditor for 2026 recommended.
Overview of voting outcomes
All director nominees elected by majority vote.
Executive compensation and annual say-on-pay frequency approved.
Deloitte & Touche LLP ratified as auditor.
Final results to be filed in Form 8-K within four business days.
Latest events from Avantor
- Q1 2026 saw flat sales, lower margins, and reaffirmed full-year guidance amid operational gains.AVTR
Q1 202629 Apr 2026 - Key votes include board elections, executive pay, and auditor ratification for 2026.AVTR
Proxy filing27 Mar 2026 - Proxy details leadership transitions, Revival strategy, and votes on directors, pay, and auditor.AVTR
Proxy filing27 Mar 2026 - Q3 2025 net loss of $711.8M on 5.3% lower sales; $500M buyback and cost actions announced.AVTR
Q3 202517 Mar 2026 - 2026 is a transition year with Revival investments, margin pressure, and strong free cash flow.AVTR
Q4 202511 Feb 2026 - Q2 2024 saw margin expansion, net income rebound, and reaffirmed full-year guidance.AVTR
Q2 20242 Feb 2026 - Cost transformation and innovation drive margin expansion and resilience amid cautious demand.AVTR
Goldman Sachs 45th Annual Global Healthcare Conference1 Feb 2026 - Cost transformation and bioprocessing momentum support a positive growth outlook.AVTR
Morgan Stanley 22nd Annual Global Healthcare Conference22 Jan 2026 - Q3 2024 saw $1.71B revenue, strong cash flow, and raised FCF guidance amid cost transformation.AVTR
Q3 202418 Jan 2026